NAD Augmentation in Diabetes Kidney Disease (NCT05759468)
NAD Augmentation to Treat Diabetes Kidney Disease: A Randomized Controlled Trial
🩺 Plain-English Summary (8th-Grade Level)
A phase 2a trial randomized, double-blind, placebo-controlled, parallel group trial to determine whether NMN administration improves DKD, as indicated by a significantly greater reduction in UACR compared with placebo administration. Eligible participants will be randomized to receive either 1000 mg NMN or placebo twice daily.
Who can join: Review the eligibility criteria below.
Location: Brigham and Women's Hospital — Boston, Massachusetts
Age range: 30 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- Brigham and Women's Hospital — Boston, Massachusetts
📞 Contact the Study Coordinator
Phone: (617) 525-9150
Email: sbhasin@bwh.harvard.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Type2diabetes
- The Effects of Glucagon on Hepatic Metabolism in People With Type 2 Diabetes After Caloric Restriction — Rochester, Minnesota
- Non-weight Bearing Exercise for Accelerated Healing of Diabetic Foot Ulcers — Ann Arbor, Michigan
- Feasibility and Adherence to a Technology-assisted Home-based Strength Training Program in Adults With Type 2 Diabetes Mellitus and Mild Cognitive Impairment — Galveston, Texas
- The CARING Study: Creating and Restoring Health Through Nutrition Guidance — Washington D.C., District of Columbia
- Understanding and Addressing Risks of Low Socioeconomic Status and Diabetes for Heart Failure — Baltimore, Maryland
Explore by condition: All Type2diabetes clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.